POS1021 THE PsABio STUDY IN ITALY: A REAL-WORLD COMPARISON OF THE PERSISTENCE, EFFECTIVENESS AND SAFETY OF USTEKINUMAB AND TUMOUR NECROSIS FACTOR INHIBITORS IN PATIENTS WITH PSORIATIC ARTHRITIS
Year: 2021
Type: article
Source: Annals of the Rheumatic Diseases
Institutions: Università Cattolica del Sacro Cuore, Agostino Gemelli University Polyclinic, Istituti di Ricovero e Cura a Carattere Scientifico, University of Campania "Luigi Vanvitelli", Humanitas University, Azienda Ospedaliero Universitaria Policlinico "G.Rodolico - San Marco", University of Florence, Sapienza University of Rome, Azienda Ospedaliera Citta' della Salute e della Scienza di Torino, University of Palermo, University of Bari Aldo Moro, University of Pisa, University of Rome Tor Vergata, Policlinico Tor Vergata, University of Verona, AOU San Giovanni di Dio e Ruggi d'Aragona, Janssen (Belgium), Janssen (Netherlands), Janssen (Italy), Inserm, Sorbonne Université, Assistance Publique – Hôpitaux de Paris, Pitié-Salpêtrière Hospital, Institut Pierre Louis d‘Épidémiologie et de Santé Publique, Medical University of Vienna
Language: English
Subfield: Rheumatology
Field: Medicine
Domain: Health Sciences
Open Access status: bronze
Funders: Eli Lilly and Company, Pfizer
OpenAlex ID: W3164075581